A 7-mm Covered TIPS Reduces Hepatic Encephalopathy Without Increasing Rebleeding in Cirrhotic Patients With Small Liver: A Randomized Study.

چکیده اصلی

BACKGROUND/AIMS: International guidelines recommend initiating transjugular intrahepatic portosystemic shunt (TIPS) placement with an 8-mm stent. However, there is an evident lack of randomized controlled trials evaluating TIPS diameters < 8 mm in cirrhotic patients with a relatively small liver. The aim of this study was to determine whether 7 mm-covered TIPS, compared with 8-mm stents, could achieve comparable shunt function with a lower incidence of hepatic encephalopathy (HE). METHODS: In this multicenter randomized controlled trial, patients with cirrhosis and relatively small liver were randomized 1:1 to receive TIPS with a 7-mm (n = 92) or 8-mm (n = 92) covered stent to prevent variceal rebleeding. The primary endpoint was the incidence of overt HE after randomization. All-cause rebleeding, orthotopic liver transplantation (OLT)-free survival and a composite of these outcomes, were designated as secondary endpoints. RESULTS: Among the 184 enrolled patients, the predominant etiologies of liver cirrhosis were hepatitis B virus infection (56.0%) and alcohol-related liver disease (20.7%). Over a median follow-up of 26.5 months, overt HE occurred in 19 patients (20.7%) in the 7-mm group and 33 patients (35.9%) in the 8-mm group. The 2-year cumulative incidence of overt HE was significantly lower in the 7-mm group than in the 8-mm group (21.4% vs. 37.2%, p = 0.02). Stent diameter, post-TIPS portosystemic pressure gradient, pre-covert HE and MELD-Na score were identified as independent risk factors for overt HE. The rates of shunt dysfunction were statistically similar between groups (8.7% vs. 8.7%, p = 1.0), as were 2-year rebleeding rates (10.9% vs. 9.8%, p = 0.81) and OLT-free survival rates (91.3% vs. 88.0%, p = 0.82). CONCLUSIONS: A 7-mm covered TIPS demonstrated comparable shunt function to an 8-mm covered stents, with a significantly lower risk of overt HE. These findings support consideration of 7-mm TIPS stents for preventing variceal rebleeding in cirrhotic patients with a small liver who are undergoing TIPS. TRAIL REGISTRATION: ClinicalTrials.gov, NCT02541825.

ترجمه فارسی چکیده

مطالعه‌ای تصادفی‌سازی‌شده و کنترل‌شده چندمرکزی برای مقایسه تیپ‌اس ۷ میلی‌متری پوشانده‌شده با تیپ‌اس ۸ میلی‌متری در بیماران کبدی سیروتیک با کبد نسبتاً کوچک انجام شد. هدف، بررسی اینکه آیا تیپ‌اس ۷ میلی‌متری می‌تواند عملکرد شانت مشابهی با خطر کمتر هپاتوآنفوئلوپاتی آشکار داشته باشد. در پیگیری میانگین ۲۶٫۵ ماهه، هپاتوآنفوئلوپاتی آشکار در گروه ۷ میلی‌متری ۲۰٫۷٪ و در گروه ۸ میلی‌متری ۳۵٫۹٪ رخ داد. تیپ‌اس ۷ میلی‌متری خطر هپاتوآنفوئلوپاتی آشکار را به طور معنی‌داری کاهش داد (۲۱٫۴٪ در برابر ۳۷٫۲٪، p = ۰٫۰۲) و عملکرد شانت و نرخ خونریزی مجدد و بقا بدون پیوند کبد را مشابه نگه داشت.

متن کامل اصلی